Technology | October 23, 2007

PTW's Device for Advanced Verification of IMRT Deliveries (DAVID) is a measurement system developed to provide a precise and reliable instrument for monitoring administered photon beams in IMRT irradiation.

According to the company, there was previously no satisfactory option for checking treatment consistency without large amounts of extra work. The newly developed DAVID system closes this gap in quality assurance for IMRT treatments. Using DAVID, patient doses are monitored in-vivo and every treatment is documented completely without any additional time required.

October 2007


Related Content

News | Radiation Oncology

July 9, 2024 — Insights from the latest Mordor Intelligence report, “Radiotherapy Market Size & Share Analysis - Growth ...

Time July 09, 2024
arrow
News | Intensity Modulated Radiation Therapy (IMRT)

March 14, 2022 — RefleXion Medical, a therapeutic oncology company pioneering the use of biology-guided radiotherapy ...

Time March 14, 2022
arrow
News | Intensity Modulated Radiation Therapy (IMRT)

October 22, 2021 — RefleXion Medical, a therapeutic oncology company pioneering biology-guided radiotherapy* (BgRT) as a ...

Time October 22, 2021
arrow
News | Intensity Modulated Radiation Therapy (IMRT)

October 27, 2020 — A preliminary analysis of photon therapy treatment group 1 from the phase II NRG Oncology clinical ...

Time October 27, 2020
arrow
News | Radiation Therapy

June 10, 2020 — A new clinical guideline from the American Society for Radiation Oncology (ASTRO) provides ...

Time June 10, 2020
arrow
News | Radiation Therapy

April 16, 2020 — RefleXion Medical, a therapeutic oncology company pioneering the use of biology-guided radiotherapy ...

Time April 16, 2020
arrow
News | Proton Therapy

January 29, 2020 — IBA (Ion Beam Applications S.A.) announced that it has signed a contract and received a major down ...

Time January 29, 2020
arrow
Technology | Image Guided Radiation Therapy (IGRT)

Accuray announced the launch of its Synchrony motion tracking and correction technology to be used with the Radixact System. This new feature adds intrafraction motion synchronization capabilities to the Radixact System, enabling real-time tracking, visualization and correction for tumor motion during treatment, with the goal of improving dose accuracy and treatment times compared to conventional radiation therapy systems. The Radixact System with Synchrony will be unveiled at the European Society for Radiotherapy & Oncology (ESTRO) meeting, April 26-30 in Milan, Italy.

Time April 24, 2019
arrow
News | Intensity Modulated Radiation Therapy (IMRT)

An analysis led by researchers at Philadelphia’s Fox Chase Cancer Center found treating localized prostate cancer with hypofractionated intensity modulated radiation therapy (HIMRT) yields equivalent disease outcomes compared with conventional intensity modulated radiation (CIMRT). It is the largest randomized single-institution study with the longest follow-up period on this topic to date.

Time October 31, 2018
arrow
News | Proton Therapy

IBA (Ion Beam Applications S.A.) announced that they completed the first two installations of the Proteus One proton therapy solution in Japan. The first installation took place at the Hokkaido Ohno Memorial Hospital in Sapporo and the other at the Narita Memorial Proton Center in Toyohashi. Both installations were successful, according to the company, as the Hokkaido Ohno Memorial Hospital installation took less than 12 months and the Narita Memorial Proton Center installation took less than 11 months.

Time July 30, 2018
arrow
Subscribe Now